Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Back

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 13, 2017
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant TherapyGeorgia Harris, Dasantha Jayamanne, Helen Wheeler, et al.
Cancers|August 28, 2025
Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future DirectionsSaad Ahmad, Dasantha Jayamanne, Sarah Bergamin, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Advances in Radiation Oncology|April 14, 2021
Introducing Computed Tomography Simulation-Free and Electronic Patient-Reported Outcomes-Monitored Palliative Radiation Therapy into Routine Care: Clinical Outcomes and Implementation ExperienceThilo Schuler, Michael Back, George Hruby, et al.
Journal of Medical Imaging and Radiation Oncology|January 25, 2019
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementMichael Back, Dasantha T Jayamanne, David Brazier, et al.
Cancers|June 2, 2021
The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical ReviewByeongsang Oh, Thomas Eade, Gillian Lamoury, et al.
BMC Cancer|February 20, 2016
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patientsKellie A Charles, Benjamin D W Harris, Carol R Haddad, et al.
Frontiers in Oncology|December 29, 2025
The gut microbiome as a potential predictive biomarker for breast cancer: emerging association and geographic differencesByeongsang Oh, Gillian Lamoury, Susan Carroll, et al.
Ecology|January 24, 2023
Coexistence between similar invaders: The case of two cosmopolitan exotic insectsMatthew B Arnold, Michael Back, Michael Daniel Crowell, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2019
Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033Linda Dirven, Jaap C Reijneveld, Martin J B Taphoorn, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|June 13, 2017
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant TherapyGeorgia Harris, Dasantha Jayamanne, Helen Wheeler, et al.
Cancers|August 28, 2025
Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future DirectionsSaad Ahmad, Dasantha Jayamanne, Sarah Bergamin, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Advances in Radiation Oncology|April 14, 2021
Introducing Computed Tomography Simulation-Free and Electronic Patient-Reported Outcomes-Monitored Palliative Radiation Therapy into Routine Care: Clinical Outcomes and Implementation ExperienceThilo Schuler, Michael Back, George Hruby, et al.
Journal of Medical Imaging and Radiation Oncology|January 25, 2019
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementMichael Back, Dasantha T Jayamanne, David Brazier, et al.
Cancers|June 2, 2021
The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical ReviewByeongsang Oh, Thomas Eade, Gillian Lamoury, et al.
BMC Cancer|February 20, 2016
Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patientsKellie A Charles, Benjamin D W Harris, Carol R Haddad, et al.
Frontiers in Oncology|December 29, 2025
The gut microbiome as a potential predictive biomarker for breast cancer: emerging association and geographic differencesByeongsang Oh, Gillian Lamoury, Susan Carroll, et al.
Ecology|January 24, 2023
Coexistence between similar invaders: The case of two cosmopolitan exotic insectsMatthew B Arnold, Michael Back, Michael Daniel Crowell, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2019
Impact of Radiation Target Volume on Health-Related Quality of Life in Patients With Low-Grade Glioma in the 2-Year Period Post Treatment: A Secondary Analysis of the EORTC 22033-26033Linda Dirven, Jaap C Reijneveld, Martin J B Taphoorn, et al.
Pageof 9